XTL Biopharmaceuticals Lt... (XTLB)
undefined
undefined%
At close: undefined
1.80
-1.64%
Pre-market Dec 13, 2024, 11:59 AM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01
Revenue - -459.00K 1.47M 28.00K 69.00K 52.00K 29.00K 23.00K -6.00K 41.00K 2.37M 938.00K - - - 5.94M 907.00K 454.00K 3.20M 3.45M - - -
Cost of Revenue - 1K 1K 1K - - 1K 3.00K 7.00K 17.00 741.00K 380.00K - - - -5.63M 110.00K 54.00K 2.80M 3.30M - - -
Gross Profit - -460.00K 1.47M 27.00K 69.00K 52.00K 28.00K 20.00K -13.00K 40.98K 1.63M 558.00K - - - 11.57M 797.00K 400.00K 400.00K 153.00K - - -
Operating Income -765.00K -880.00K -1.03M -948.00K -842.00K -793.00K -1.25M -2.56M -3.61M -2.02M -2.89M -2.36M -1.16M -1.26M 2.57M -9.59M -25.73M -16.05M -14.38M -16.78M 14.56M -17.71M -15.12M
Interest Income 36.00 36.00K 8.00K 33.00K 93.00K 87.00K 16.00K - - 10.00K 10.00K 43.00K 45.00K 2.00K 3.00K 317.00K 668.00K 1.06M 503.00K 352.00K 352.00K - -
Pretax Income -1.78M -1.35M 435.00K -782.00K -1.35M 2.99M -781.00K -2.54M -3.62M -2.12M -3.71M -1.74M -1.21M -1.26M 2.56M -9.28M -25.14M -14.90M -13.94M -16.42M -14.21M -17.11M -
Net Income -1.78M -2.31M 1.90M -616.00K -1.28M 2.99M -781.00K -2.54M -4.31M -2.53M -2.48M -1.39M -1.21M -1.26M 2.59M -9.25M -24.94M -15.13M -14.02M -16.47M -14.29M -17.14M -12.67M
Selling & General & Admin 734.00K 850.00K 1.00M 910.00K 807.00K 755.00K 1.19M 1.26M 1.41M 1.72M 3.67M 3.55M 1.00M 1.22M 2.43M 5.14M 5.58M 5.58M 5.46M 4.13M 3.10M 3.64M 3.00M
Research & Development 31.00K 30.00K 30.00K 38.00K 35.00K 38.00K 43.00K 443.00K 578.00K 278.00K 113.00K 99.00K 158.00K 64.00K - 10.39M 20.95M 10.87M 7.54M 12.79M 11.10M 13.16M 11.05M
Other Expenses - - - - - - 9.00K 8.00K 7.00K 25.00K 71.00K -802.00K 12.00K -30.00K -139.00K - - - - - -28.77M 916.00K 1.07M
Operating Expenses 765.00K 880.00K 1.03M 948.00K 842.00K 793.00K 1.25M 1.71M 2.00M 2.02M 3.85M 3.70M 1.16M 1.26M 2.29M 15.53M 26.53M 16.45M 13.00M 16.93M -14.56M 17.71M 15.12M
Interest Expense - 468.00K 21.00K 17.00K 29.00K 80.00K 29.00K 16.00K 6.00K 35.00K 35.00K 15.00K 8.00K 7.00K 2.00K 3.00K 4.00K - - - - - -
Selling & Marketing Expenses - - - - - - - - - - 1.69M 848.00K -76.00K - - - - - - - - - -
Cost & Expenses 765.00K 880.00K 1.03M 948.00K 842.00K 793.00K 1.25M 1.71M 2.00M 2.02M 4.59M 4.08M 1.16M 1.26M 2.29M 15.53M 26.64M 16.50M 15.79M 20.23M -14.56M 17.71M 15.12M
Income Tax - 961.00K -1.47M -166.00K -69.00K -7.64M -457.00K 832.00K 2.31M 505.00K 458.00K -1.79M -1.22M -1.26M -23.00K -31.00K -206.00K 227.00K 78.00K 49.00K 78.00K 27.00K 12.67M
Shares Outstanding (Basic) 544.95M 5.45M 5.32M 5.14M 5.14M 5.14M 4.70M 2.74M 2.64M 2.31M 2.24M 2.18M 1.94M 11.34M 5.86M 585.54K 456.99K 403.48K 340.25K 269.46K 2.23M 2.22M 2.22M
Shares Outstanding (Diluted) 544.91M 5.45M 6.16M 5.14M 5.14M 5.14M 4.70M 2.74M 2.64M 2.31M 2.24M 2.18M 1.94M 11.34M 5.88M 585.54K 456.99K 403.48K 3.37M 2.75M 2.23M 2.22M 2.22M
EPS (Basic) -0.00 -0.42 0.36 -0.12 -0.25 0.58 -0.17 -0.93 -1.63 -1.09 -1.11 -0.64 -0.62 -0.11 0.44 -15.79 -54.57 -37.5 -41.19 -61.13 -6.39 -7.71 -5.71
EPS (Diluted) -0.00 -0.42 0.31 -0.12 -0.25 0.58 -0.17 -0.93 -1.63 -1.09 -1.11 -0.64 -0.62 -0.11 0.44 -15.79 -54.57 -37.5 -4.16 -6 -6.39 -7.71 -5.71
EBITDA -764.00K -879.00K -1.03M -947.00K - -792.00K -1.25M -2.56M -2.00M -1.97M -190.00K -2.17M -1.11M -1.22M 2.58M -18.40M -25.03M -15.40M -12.37M -16.46M 15.36M -17.71M -15.12M
Depreciation & Amortization 1K 1K 1K 1K 842.00K 1K 1K 3.00K 7.00K 53.00K 313.00K 136.00K 94.00K 42.00K 13.00K 39.00K 108.00K 243.00K 242.00K 319.00K 440.00K - -